These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25011933)

  • 21. Forgone Health and Economic Benefits Associated with Socioeconomic Differences in Organized Cervical Cancer Screening.
    Hsieh VC; Chen ZJ; Liu CC; Chiang JH; Shieh SH; Hsieh MS
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3755-3762. PubMed ID: 31870118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-standardized expected years of life lost: quantification of cancer severity.
    Wang Y; Chiang CJ; Lee WC
    BMC Public Health; 2019 May; 19(1):486. PubMed ID: 31046731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of Korea's National Cervical Cancer Screening Program.
    Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
    Asian Pac J Cancer Prev; 2013; 14(7):4329-34. PubMed ID: 23991998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expected years of life lost for six potentially preventable cancers in the United States.
    Liu PH; Wang JD; Keating NL
    Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan.
    Tang CH; Cheng WF; Jiang JH; You SL; Huang LW; Hsieh JY; Mukherjee P; Van Kriekinge G; Lee C
    Asian Pac J Cancer Prev; 2019 May; 20(5):1377-1387. PubMed ID: 31127896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study.
    Devine A; Vahanian A; Sawadogo B; Zan S; Bocoum FY; Kelly H; Gilham C; Nagot N; Ong JJ; Legood R; Meda N; Miners A; Mayaud P;
    PLoS One; 2021; 16(3):e0248832. PubMed ID: 33765011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.
    Dickinson JA; Stankiewicz A; Popadiuk C; Pogany L; Onysko J; Miller AB
    BMC Public Health; 2012 Nov; 12():992. PubMed ID: 23158654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
    Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
    BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world cost-effectiveness of laparoscopy versus open colectomy for colon cancer: a nationwide population-based study.
    Liao CH; Tan EC; Chen CC; Yang MC
    Surg Endosc; 2017 Apr; 31(4):1796-1805. PubMed ID: 27538935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
    Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
    Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer prevention in Morocco: a model-based cost-effectiveness analysis.
    Messoudi W; Elmahi T; Nejjari C; Tachfouti N; Zidouh A; Saadani G; Moriña D; Diaz M
    J Med Econ; 2019 Nov; 22(11):1153-1159. PubMed ID: 31135231
    [No Abstract]   [Full Text] [Related]  

  • 35. Costs of integrating cervical cancer screening at an HIV clinic in Kenya.
    Vodicka EL; Babigumira JB; Mann MR; Kosgei RJ; Lee F; Mugo NR; Okech TC; Sakr SR; Garrison LP; Chung MH
    Int J Gynaecol Obstet; 2017 Feb; 136(2):220-228. PubMed ID: 28099724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan.
    Chu PC; Hwang JS; Wang JD; Chang YY
    J Formos Med Assoc; 2008 Jan; 107(1):54-63. PubMed ID: 18218578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of HPV-based cervical screening based on first year results in the Netherlands: a modelling study.
    Jansen E; Naber SK; Aitken CA; de Koning HJ; van Ballegooijen M; de Kok I
    BJOG; 2021 Feb; 128(3):573-582. PubMed ID: 32638462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
    Chu PC; Wang JD; Hwang JS; Chang YY
    Value Health; 2008 Dec; 11(7):1102-9. PubMed ID: 18489497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system.
    Chow IH; Tang CH; You SL; Liao CH; Chu TY; Chen CJ; Chen CA; Pwu RF
    Br J Cancer; 2010 Dec; 103(12):1773-82. PubMed ID: 21102588
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.